Literature DB >> 29192996

British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017.

K E Harman1, D Brown2, L S Exton3, R W Groves4, P J Hampton5, M F Mohd Mustapa3, J F Setterfield4,6, P D Yesudian7.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29192996     DOI： 10.1111/bjd.15930

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  27 in total

1.  Refractory pemphigus foliaceous treated with rituximab.

Authors:  Fatima Awdeh; Eimear Gilhooley; Ciara O Grady; Maureen Connolly
Journal:  BMJ Case Rep       Date:  2019-05-29

Review 2.  Life-threatening skin conditions presenting to critical care.

Authors:  M Bromley; S Marsh; A Layton
Journal:  BJA Educ       Date:  2021-07-23

3.  Targeting the neonatal Fc receptor in pemphigus: safety first.

Authors:  G Micevic; S N Lo; N Rajan
Journal:  Br J Dermatol       Date:  2021-12-27       Impact factor: 11.113

4.  Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study.

Authors:  Khalaf Kridin; Christoph M Hammers; Ralf J Ludwig; Dana Tzur Bitan; Arnon D Cohen
Journal:  Acta Derm Venereol       Date:  2021-09-03       Impact factor: 3.875

5.  Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study.

Authors:  Xingli Zhou; Liangliang Cheng; Yiyi Wang; Hui Gou; Ke Ju; TianJiao Lan; Tongying Zhan; GaoJie Li; Yuanxia Gu; Yeting Sun; Yan Xu; Yukun Sun; Yanhong Zhou; Wei Li
Journal:  J Dermatol       Date:  2021-12-05       Impact factor: 3.468

6.  Oral pemphigus vulgaris: dentists take-home message.

Authors:  Aya Al-Harbawee; Karim Kassam; Ankur Nilesh Patel; Hannah Cottom; Leo Cheng
Journal:  Clin Case Rep       Date:  2021-07-09

Review 7.  Bullous Autoimmune Dermatoses–Clinical Features, Diagnostic Evaluation, and Treatment Options.

Authors:  Nina van Beek; Detlef Zillikens; Enno Schmidt
Journal:  Dtsch Arztebl Int       Date:  2021-06-18       Impact factor: 8.251

8.  Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris.

Authors:  Sharon Baum; Tal Raviv; Sarit Gilboa; Felix Pavlotsky; Aviv Barzilai
Journal:  Acta Derm Venereol       Date:  2020-10-06       Impact factor: 3.875

Review 9.  Emerging treatment options for the management of pemphigus vulgaris.

Authors:  Khalaf Kridin
Journal:  Ther Clin Risk Manag       Date:  2018-04-27       Impact factor: 2.423

Review 10.  Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies.

Authors:  Haiqin Zhu; Meng Pan; Wenzhe Zhao; Jingying Wang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-04       Impact factor: 8.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.